Publications by authors named "Emily Huneycutt"

Claim this Profile
L
Lesinurad, a Selective URAT-1 Inhibitor With a Novel Mechanism in Combination With a Xanthine Oxidase Inhibitor, for Hyperuricemia Associated With Gout.
Emily Huneycutt, Chase Board, Jennifer N Clements

J Pharm Practยท January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis